Development of vaccines against SARS-CoV-2 has been rapid, but the rise of variants forces scientists to frequently modify treatments. Ideally, therapies would target mutation-resistant viral proteins, but this has proven ...
Biochemistry
Apr 26, 2023
0
44
The Allain (IBC), Gossert (BNSP) and Leitner (IMSB) groups investigated the druggability of the SARS-CoV-2 Nucleocapsid protein RNA interactions by a hybrid structure determination approach, which led to the identification ...
Molecular & Computational biology
Apr 3, 2023
0
1
A new study led by Worcester Polytechnic Institute (WPI) brings into sharper focus the structural details of the COVID-19 virus, revealing an elliptical shape that "breathes," or changes shape, as it moves in the body. The ...
Cell & Microbiology
Mar 30, 2023
0
180
The rapid spread of COVID-19 may have been partly due to changes in the structure of the SARS-CoV-2 virus wrought by an early mutation in its genome, a detailed analysis by RIKEN researchers suggests. The finding, published ...
Molecular & Computational biology
Mar 27, 2023
0
55
The highly contagious canine distemper virus is dangerous to dogs and wild life animals. It is also closely related to the equally highly contagious measles virus. Researchers at the University of Bern and the Zurich University ...
Molecular & Computational biology
Mar 15, 2023
0
74
University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and forms a natural protective barrier in the human body.
Cell & Microbiology
Feb 9, 2023
0
525
Researchers at University of California San Diego and UC Riverside have further elucidated the molecular pathway used by the SARS-CoV-2 virus to infect human lung cells, identifying a key host-cell player that may prove a ...
Cell & Microbiology
Jan 23, 2023
0
58
A team led by scientists at Scripps Research and the University of Amsterdam has achieved an important goal in virology: mapping, at high resolution, critical proteins that stud the surface of the hepatitis C virus (HCV) ...
Molecular & Computational biology
Oct 20, 2022
0
62
Researchers have identified a promising strategy for development of broad-spectrum antiviral therapies that centers around promoting a strong immune response capable of stopping a number of viruses in their infectious tracks.
Biochemistry
Oct 10, 2022
0
91
A new drug designed by scientists at Scripps Research can turn the COVID-19 virus into a harbinger of its own doom.
Biochemistry
Sep 29, 2022
0
803
